tiprankstipranks
Advertisement
Advertisement

Zhong Ji Longevity Science Delays Circular on 25% Cell Lab Stake Deal

Story Highlights
  • Zhong Ji Longevity Science is delaying its shareholder circular on acquiring 25% of Asian Integrated Cell Laboratory, now due by March 6, 2026.
  • The extended timetable postpones clarity on a strategic cell-lab investment that could reshape the group’s growth path and capital structure for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Zhong Ji Longevity Science Delays Circular on 25% Cell Lab Stake Deal

Claim 55% Off TipRanks

Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has shared an update.

Zhong Ji Longevity Science Group Limited has announced a further delay in sending a shareholder circular related to its planned acquisition of a 25% stake in Asian Integrated Cell Laboratory Limited, which will be settled through the issue of convertible notes under a specific mandate. The circular, which will contain detailed transaction terms, independent board and financial adviser assessments, and financial information on the target company, is now expected to be dispatched on or before 6 March 2026, reflecting the additional time needed to finalize required information and slightly extending the timetable for shareholder review and approval.

The postponement means investors will wait longer for full disclosure on a deal that could deepen the group’s involvement in cell-based and longevity-focused laboratory services, potentially influencing its growth trajectory and capital structure. While the company frames the delay as procedural, it extends the period of uncertainty around the transaction’s completion and its implications for minority shareholders, governance oversight, and the valuation impact of issuing new convertible notes.

The most recent analyst rating on (HK:0767) stock is a Sell with a HK$0.47 price target. To see the full list of analyst forecasts on Zhong Ji Longevity Science Group Limited stock, see the HK:0767 Stock Forecast page.

More about Zhong Ji Longevity Science Group Limited

Zhong Ji Longevity Science Group Limited is a Bermuda-incorporated company listed in Hong Kong that focuses on longevity and life-science-related businesses. The group is expanding its presence in advanced biomedical services and technologies through strategic investments and acquisitions in the region.

Average Trading Volume: 485,353

Technical Sentiment Signal: Sell

Current Market Cap: HK$302.4M

For a thorough assessment of 0767 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1